Lacrifluid

Carbomer 980, the active ingredient in Lacrifluid, is an excipient presented as an ophthalmic solution for ocular use. It enhances the viscosity of eye drops to improve lubrication of the ocular surface and increase residence time, supporting comfort in patients who require eye‑drop therapy.

GNH USA supplies Lacrifluid as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lacrifluid, containing Carbomer 980, is employed as an ophthalmic vehicle to improve ocular surface conditions. - Dry Eye Syndrome: improves tear film stability and ocular surface comfort. - Post‑surgical ocular care: provides prolonged lubrication after eye surgery, aiding healing. - Contact lens discomfort: reduces friction and dryness for lens wearers.

Lacrifluid may cause ocular reactions, most of which are mild and transient.

Common Side Effects: - Transient blurred vision: temporary visual disturbance after instillation. - Mild ocular irritation: slight stinging or burning sensation. - Redness of the conjunctiva: mild injection of the eye. - Temporary tearing: increased lacrimation shortly after use.

Serious or Rare Side Effects: - Allergic reaction: swelling, itching, or rash around the eye. - Corneal ulceration: persistent pain, discharge, or vision loss. - Increased intra‑ocular pressure: may require monitoring in susceptible individuals.

When using Lacrifluid, consider the following precautions to ensure safe administration. - Assess patient history: verify no known hypersensitivity to carbomers or related polymers. - Monitor ocular condition: watch for signs of infection or worsening inflammation. - Avoid contaminated containers: use a new sterile dropper for each patient. - Caution with contact lenses: remove lenses before instillation and re‑insert after a few minutes. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Lacrifluid may interact with other ophthalmic preparations, affecting comfort or drug performance.

Major Interactions (Avoid): - Concurrent use with preservative‑containing eye drops: may increase ocular irritation. - Mixing with strong acidic or basic ophthalmic solutions: can alter gel stability.

Moderate Interactions (Monitor Closely): - Co‑administration with contact lens cleaning solutions: monitor for discomfort. - Use with rapid‑action ocular medications: may delay absorption due to increased viscosity. - Simultaneous use with anti‑inflammatory eye drops: observe for reduced efficacy.